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1

Editor, The Journal of Experimental Medicine
Editor-in-Chief, The Journal of Cell Biology

We live in a scientific universe in which
subject boundaries are increasingly
porous. Department definitions in
many institutions are either close to
meaningless or nonexistent, and many
faculty count themselves as active participants in at least two, if not more,
of the major disciplines of biology.
Thus, it is with great pleasure that we
announce a new cross-listing project
for the JEM and the JCB.
An increasing number of papers in
the two journals include subject matter
vital to both immunologists and cell
biologists. For these papers, we will
include a listing not only on the table
of contents of the hosting journal, but
also on the online table of contents of
the sister journal (both the JEM and
JCB are published by the Rockefeller
University Press). JCB subscribers will
get free access to the listed JEM articles,
and vice versa. The relevant papers
will be identified by the editors, often
on the recommendations of our re-

viewers or submitting authors. This
arrangement addresses the need to
bring together the fields of cell biology,
immunology, human disease, and
microbial pathogenesis.
Based on our subscription lists, the
JEM and JCB readerships do not overlap much. Thus, the cross-listing will
give extra exposure to papers at the
interface between these subject areas,
and make these papers accessible to
readers who might otherwise not have
seen a given paper, were it to have
appeared in only one journal. Basic
mechanisms of cellular motility and
organization will be brought to the
attention of those studying immune
activation, immune cell interactions
will be highlighted for those studying
signaling, and a wide array of pathogens and human disease states will be
featured as potential models for cell
biology investigation.
The JEM and JCB are both leading
journals in their fields, and immunology
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and cell biology represent two of the
biggest fields in terms of the number
of papers and journals published.
Readers are struggling just to keep up
with what is published in the top tier
journals in their own field. We hope
to do some of the work for these readers
by alerting them to relevant content
in another leading journal—a journal
that they might not have time to scan
in its entirety.
By cross-listing relevant content,
we feel we will enhance the cause of
communication between scientific
communities that do not interact nearly
as much as they should. Further, by
increasing the visibility of papers at
the interface of experimental medicine
and cell biology, both the JCB and the
JEM—not-for-profit journals edited
by your colleagues and whose contents
are available free online 6 months after
publication—will become even more
attractive choices for submitting your
best work. Let the collaborations begin!
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